- This event has passed.
Engaging HCPs in an AI-Powered, Omnichannel World
September 19, 2023 @ 12:30 pm - 1:00 pm EDT
Are your customer-facing teams ready to compete and win in an AI-powered omnichannel world?
In the last 18 months, biopharma has crossed a customer engagement tipping point: Digital HCP engagement is now bigger than in-person engagement in both quantity & quality, but not in impact – and that’s the rub.
The question is: How do we empower our customer-facing teams to leverage all the new digital tools, content, and channels to drive growth and create a better treatment experience than the competition?
Join this 30-minute LTEN webinar, sponsored by Quantum Learning, for an enlightening look at how to train your customer-facing teams to thrive in an AI-powered omnichannel world. We’ll talk about the key role training plays by providing the skills and insights needed to deliver omnichannel engagement that truly moves the needle. You will learn:
- What omnichannel customer engagement is, why it matters and what it looks like in practical, everyday terms.
- How L&D can play a strategic role in elevating the way your salespeople, field reimbursement managers, district managers and other customer-facing roles, work together to do omnichannel HCP engagement at an entirely new level.
- How to organize all the complex tools and channels into a simple framework that empowers your customer-facing teams to drive brand growth and create a seamless experience for the physician, the patient and the practice.
Register today for this free, LTEN webinar. Not an LTEN member? Join today and realize the value.
Register
Presenter:
Fred Marshal, CEO and Founder
Quantum Learning
Fred Marshall is CEO and founder of Quantum Learning and is an expert in competitive customer engagement and has consulted with some of the world’s most respected companies, including Apple, Genentech and Pfizer. He’s personally trained more than 100,000 people and he’s been quoted in LTEN Focus on Training magazine, PharmaVOICE, Entrepreneur magazine and The Wall Street Journal.